XML 39 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Net Product Sales (Tables)
3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue from External Customers by Geographic Areas
Net product sales by customer geographic location were as follows (in millions):
Three Months Ended March 31,
20262025
United States$73 $31 
Europe239 — 
Rest of world40 55 
Total $352 $86 
Schedule of Disaggregation of Revenue
Net product sales by product type were as follows (in millions):
Three Months Ended March 31,
20262025
COVID(1)
$345 $84 
RSV
Total $352 $86 
_______
(1)Includes sales of Spikevax and mNEXSPIKE.
The following table summarizes product sales provision adjustments for the periods presented (in millions):
Three Months Ended March 31,
20262025
Gross product sales $350 $105 
Product sales provision:
Wholesaler chargebacks, discounts and fees
11 (22)
Returns, rebates and other fees
(9)
Total product sales provision adjustments
$$(19)
Net product sales $352 $86 
The following table summarizes other revenue for the periods presented (in millions):
Three Months Ended March 31,
20262025
Stand-ready manufacturing revenue
$32 $12 
Collaboration revenue (Note 5)
Grant revenue— 
Licensing and royalty revenue
— 
Total other revenue$37 $22 
Schedule of Changes in Balances of Receivables and Contract Liabilities
The following table summarizes the activities related to product sales provision recorded as accrued liabilities for the three months ended March 31, 2026 (in millions):
Returns and other fees
Balance at December 31, 2025$(509)
Provision related to sales made in current period
(9)
Provision related to sales made in prior periods
— 
Payments and returns related to sales made in current period — 
Payments and returns related to sales made in prior year
48 
Balance at March 31, 2026$(470)
The following table summarizes the activities in deferred revenue for the three months ended March 31, 2026 (in millions):
December 31, 2025AdditionsDeductionsMarch 31, 2026
Other revenue$145 $53 $(37)$161 
Net product sales
107 — (12)95 
Total deferred revenue$252 $53 $(49)$256